Dylan Boyd
Acute Care · Hattiesburg, MSNPI 1891357588
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 842 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,054, 3.4 times the $1,198 reported in 2021. Among acute care clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 842 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Mylan Specialty L.p.$1K
- Boehringer Ingelheim$973
- Grifols USA, LLC$969
- Sanofi$743
- plus $6K from 32 others
What the payments were for
- Food & beverage$15,008100%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 138 | $3,083 |
| GSK | 175 | $2,039 |
| Mylan Specialty L.p. | 58 | $1,107 |
| Boehringer Ingelheim | 60 | $973 |
| Grifols USA, LLC | 51 | $969 |
| Sanofi | 36 | $743 |
| Regeneron Healthcare Solutions, Inc. | 24 | $558 |
| United Therapeutics Corporation | 26 | $499 |
| Viatris Specialty LLC | 32 | $454 |
| Jazz Pharmaceuticals Inc. | 20 | $451 |
| Electromed, Inc. | 31 | $422 |
| Actelion Pharmaceuticals US, Inc. | 20 | $396 |
| Baxter Healthcare | 14 | $372 |
| Mallinckrodt Hospital Products Inc. | 17 | $349 |
| Insmed, Inc. | 21 | $297 |
| ANI Pharmaceuticals, Inc. | 14 | $276 |
| Merck | 13 | $273 |
| Amgen | 9 | $228 |
| Verona Pharma, Inc. | 13 | $221 |
| Shionogi Inc | 12 | $197 |
| Axsome Therapeutics, Inc. | 6 | $164 |
| Bayer | 9 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $135 |
| Inspire Medical Systems, Inc. | 6 | $114 |
| Pulmonx Corporation | 4 | $97 |
| La Jolla Pharmaceutical Company | 5 | $95 |
| Pfizer | 5 | $86 |
| Philips North America LLC | 3 | $55 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $33 |
| Boston Scientific | 2 | $32 |
| Genentech USA, Inc. | 1 | $25 |
| 3b Medical, Inc. | 2 | $24 |
| Liquidia Technologies, Inc. | 1 | $20 |
| Harmony Biosciences LLC | 1 | $19 |
| AbbVie | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,051 in reported general payments places this provider in the 95th percentile of 223 acute care providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 718 | $581,662 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 235 | $182,950 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 218 | $142,664 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 215 | $108,707 |
| Spiriva RespimatTiotropium Bromide | 133 | $100,873 |
| Breo ElliptaFluticasone/Vilanterol | 204 | $92,709 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 59 | $37,419 |
| Incruse ElliptaUmeclidinium Bromide | 82 | $28,861 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 760 | $28,325 |
| SymbicortBudesonide/Formoterol Fumarate | 99 | $26,504 |
| Spiriva HandihalerTiotropium Bromide | 35 | $22,890 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 97 | $15,237 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 22 | $14,195 |
| Ventolin HfaAlbuterol Sulfate | 131 | $9,211 |
| Arnuity ElliptaFluticasone Furoate | 36 | $8,783 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $2,039 | $820,7211,255 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Combivent Respimat | $973 | $280,956410 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $3,083 | $223,649356 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 223 acute care providers in Mississippi.
Other acute care in Hattiesburg
- Kimberly GonzalesHattiesburg$10K
- Billy ChancellorHattiesburg$9K
- Brad MasseyHattiesburg$4K
- Ronald TynesHattiesburg$3K
- Garrett BondHattiesburg$2K
- Christopher BellTupelo$348K
- Kathleen ArnoldOcean Springs$217K
- Gavin GistOxford$42K
- Jamie DamicoOcean Springs$17K
- Melinda ClarkStarkville$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.